Delta4 At BIO-Europe
Delta4 Reflects on a Milestone BIO-Europe Spring 2025 in Milan Delta4 is pleased to share highlights from this year’s BIO-Europe Spring 2025, held in Milan, Italy—an event that marked our most successful participation to date. Representing Delta4 were Kurt Herpel (CEO) and Klaus Kratochwill (CSO), who spent two fully packed days in one-on-one meetings with […]
Delta4: A Trusted Partner in EU Horizon Research Projects
Delta4 is proud to announce its participation in two significant EU Horizon research projects: PICKED (Personalized Medicine in Chronic Kidney Disease) and PROMOTE (Prostate Cancer Omics Mediated Intervention). Horizon Europe is the world’s largest research funding program, focusing on advancing health, biomedical research, data science, and AI/ML. With a total budget of nearly EUR 100 […]
Delta4 Featured in the Finanz und Wirtschaft (FuW)
Delta4 is honored to have been featured in a recent article by Finanz und Wirtschaft, highlighting our pioneering work in AI-driven drug repurposing. The article sheds light on how our AI-powered platform, Hyper-C, identifies novel therapeutic uses for existing drugs, offering hope for more efficient and effective treatment strategies for a range of complex conditions. […]
Biomedical Knowledge Graphs for Drug Discovery: Delta4’s Innovative Approach
The term “knowledge graph” describes the process of storing data in a graph-structured topology. A graph database consists of three main elements: nodes, edges, and properties. Nodes symbolize instances or entities, such as proteins, diseases, or tissues. Edges, otherwise known as relationships, provide a contextual connection between nodes. Properties, on the other hand, enrich both […]
Pioneering the Future of Nephrotic Syndrome Research with ARREST-NEPHROSIS
Nephrotic Syndrome affects millions globally, presenting a significant health burden with its hallmark symptoms of severe proteinuria and edema. The quest for advanced treatments underscores the crucial role of biobanks and registries, which are instrumental in propelling medical research and innovation. At the forefront of this effort is ARREST-NEPHROSIS, an Austrian registry that exemplifies how […]
Digital Health Envision Summit
We are delighted to announce that Dr. Klaus Kratochwill, CSO, and Dr. Paul Perco, Computational Biology Lead of Delta4, are looking forward to attending the prestigious 2023 Digital Health Envision Summit to be held in London, UK. The summit, renowned for being a hub of innovation in healthcare and neurology, aligns seamlessly with Delta4’s mission […]
Case Study: Unravelling the Multifaceted Potential of Iguratimod with Delta4’s Hyper-C Platform
Diving deep into the realms of computational drug repurposing, Delta4 leveraged its state-of-the-art Hyper-C platform with an ambitious objective: to comprehensively understand and broaden the applications of the anti-inflammatory compound iguratimod. At the heart of this project was the creation of a molecular Mechanism of Action (MoA) model. This intricate model was meticulously constructed around […]
Delta4 at RExPO: Pushing the Boundaries of Drug Repurposing
We are thrilled to announce that Delta4 will be in attendance at this year’s RExPO23, a landmark event in the realm of Systems Medicine, Artificial Intelligence, and Drug Repurposing. As pioneers in AI-enabled drug repurposing and indication expansion, our presence underscores our commitment to fostering global collaborations and accelerating advancements in this transformative field. Dr. […]
Reactome Spotlights Delta4’s Computational Drug Repositioning of Clopidogrel for FSGS
We are honored to announce that our publication on the computational drug repositioning of clopidogrel has been highlighted in the Reactome research spotlight. This notable recognition from a reputable bioinformatics database underscores the potential of our innovative approach in addressing Focal Segmental Glomerulosclerosis (FSGS), a severe glomerular lesion associated with nephrotic syndrome and a high […]
Delta4’s Innovation Shines: OntoloViz Article Published in Bioinformatics Advances Journal
We are thrilled to announce that our journal article, titled “OntoloViz: a GUI for interactive visualization of ranked disease or drug lists using the MeSH and ATC ontologies,” has been published in the esteemed Bioinformatics Advances Journal. This publication accentuates Delta4’s continuous endeavor to push the boundaries of TechBio innovation, bridging computational power and biological […]